Drug Farm Secures U.S. FDA Orphan Drug Designation for DF-003 in Treating ROSAH Syndrome Drug Farm has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its investigational therapy DF-003, a small molecule…
Aledade Partners Demonstrate Superior Hypertension Control, Surpassing Large Health Systems in New Case Study Aledade, a physician-led organization recognized as a national leader in advancing value-based care, has released the findings of a new case study highlighting the effectiveness of…
Long Bridge Medical Secures U.S. Food and Drug Administration Clearance to Launch Pivotal U.S. Study of LensOne Prosthetic Capsular Bag Long Bridge Medical, Inc. has reached an important regulatory milestone with the clearance from the U.S. Food and Drug Administration…
Aerin Medical Achieves Milestone of Treating Over 200,000 Patients with Its Minimally Invasive Therapies for Chronic Nasal Disorders Aerin Medical Inc., a recognized innovator in minimally invasive therapies for chronic nasal conditions, has announced a major milestone in its clinical…
Imperative Care Launches CLEAR-IT Clinical Study to Advance Standards in Peripheral Thromboembolism Treatment Imperative Care Inc has announced a significant milestone in its efforts to advance treatment options for patients with thromboembolic diseases, marking the enrollment of the first patient…
Roseman University Establishes 120,000-Square-Foot Bioventures Hub in Las Vegas to Accelerate Life Science Innovation Roseman University of Health Sciences has officially launched Roseman Bioventures in Las Vegas, marking a significant step forward in the institution’s mission to accelerate the translation…
Celltrion Unveils KRW 1.2 Trillion Investment to Expand Drug Substance Manufacturing in Songdo, Boosting Total Capacity to 570,000 Liters Celltrion has unveiled an ambitious large-scale investment strategy exceeding KRW 1 trillion aimed at significantly expanding its global manufacturing footprint and…
BioNTech presents new ELCC 2026 data underscoring the strength and differentiation of its late-stage lung cancer pipeline BioNTech has announced that it will showcase new clinical data from its expanding lung cancer pipeline at the European Lung Cancer Congress 2026,…
Celltrion unveils KRW 1.2 trillion Songdo expansion, boosting DS production capacity by 180,000L to a total of 570,000L Celltrion has unveiled an ambitious and far-reaching investment strategy aimed at significantly expanding its global manufacturing footprint, reinforcing its position in the…
ImmunityBio Secures Macau SAR Authorization for ANKTIVA® in BCG-Unresponsive NMIBC with CIS With or Without Papillary Tumors ImmunityBio, today announced that the Pharmaceutical Administration Bureau (ISAF) of the Macau Special Administrative Region of the People’s Republic of China has granted…
Novartis to Acquire Next-Generation Pan-Mutant PI3Kα Inhibitor, Enhancing Its Breast Cancer Treatment Pipeline Novartis has taken another significant step to strengthen its oncology pipeline, announcing a strategic agreement with Synnovation Therapeutics to acquire SNV4818, a next-generation pan-mutant–selective PI3Kα inhibitor. The…
Royalty Pharma Strengthens Executive Leadership Team to Support Strategic Growth and Investment Expansion Royalty Pharma plc has announced a significant expansion of its senior leadership team, underscoring the company’s continued growth ambitions and its commitment to strengthening its position as…